Defiance Daily Target 2X Long SOFI ETFSOFX

The SOFX ETF (Defiance Daily Target 2X Long SOFI ETF) surged 4.2% on 24 July 2026 amid a broad rally in financial stocks, though its official fact sheet still fails to disclose updated assets under management (AUM) or average daily volume. The fund, which tracks a concentrated version of the Nasdaq-100 excluding software companies, charges an expense ratio of 0.75% while warning of 'significant volatility' in its prospectus.

Defiance ETFs markets SOFX as a play on 'the next generation' of tech-adjacent giants, but its top holdings include UnitedHealth Group (4.3%), Walmart (3.8%), and Johnson & Johnson (3.2%)-hardly the 'ex-software' disruptors implied by its name. The fund’s 2x daily leverage mechanism, designed to double the index’s daily returns, risks compounding losses during prolonged downturns, a detail buried in footnotes rather than bolded in brochures.

SEC filings show no recent amendments to SOFX’s investment strategy, though its prospectus explicitly states the fund may use derivatives to achieve leverage, which increases counterparty risk. FINRA’s Fund Analyzer notes the ETF has a 5-year 'risk rating' of 'extreme,' a label Defiance’s marketing materials curiously omit. The fund’s official website also lacks historical performance data beyond 12-month returns, raising questions about transparency for long-term investors.

Technical analysts tracking SOFX on Nasdaq’s platform note its 50-day moving average has crossed below the 200-day average, a 'death cross' pattern often cited as a bearish signal. However, the fund’s issuer provides no official chart commentary, leaving traders to interpret its concentrated swings without issuer guidance. The lack of disclosed liquidity metrics also complicates risk assessment, as the ETF’s average trading volume remains unlisted on public exchanges.